Adverse Events Module

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module

Ignite Creation Date: 2025-12-24 @ 6:31 PM

Ignite Modification Date: 2025-12-25 @ 4:02 PM

NCT ID: NCT02455557

Description: None

Frequency Threshold: 0

Time Frame: Start date of intervention until 30 days after the last intervention or until the event has resolved, the study participant is lost to follow-up, the start of a new treatment, or until the study investigator assesses the event(s) as stable or irreversible, will be reported.

Study: NCT02455557

Study Brief: SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Event Groups(If Any):

Event Groups

Title	Description	Deaths # Affected	Deaths # At Risk	Serious # Affected	Serious # At Risk	Other # Affected	Other # At Risk	View

Treatment (SurVaxM, Temozolomide)	Patients receive the first priming dose of SVN53-67/M57-KLH peptide vaccine in emulsion with montanide ISA 51 SC and sargramostim SC within 7-28 days after completion of chemoradiation. Treatment repeats every 2 weeks for a total of 4 doses in the vaccine priming phase and then every 12 weeks during the adjuvant phase in the absence of disease progression or unacceptable toxicity. Patients also receive standard adjuvant temozolomide PO or IV on days 1-5. Treatment repeats every 28 days for 6 courses or more (at the discretion of the investigator) in the absence of disease progression or unacceptable toxicity. Patients may then receive maintenance SVN53-67/M57-KLH peptide vaccine in emulsion with montanide ISA 51 SC and sargramostim SC every 12 weeks in the absence of disease progression or unacceptable toxicity. Laboratory Biomarker Analysis: Correlative studies Montanide ISA 51 VG: Given SC Sargramostim: Given SC SVN53-67/M57-KLH Peptide Vaccine: Given SC Temozolomide: Given PO or IV	36	None	22	66	65	66	View

Serious Events(If Any):

Serious Events

Term	Type	Organ System	Vocab	View

Fatigue	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Gait disturbance	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Influenza like illness	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site reaction	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Oedema peripheral	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Pyrexia	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Bronchitis	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Colonic abscess	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Influenza	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Meningitis aseptic	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Fall	SYSTEMATIC_ASSESSMENT	Injury, poisoning and procedural complications	None	View
Wound complication	SYSTEMATIC_ASSESSMENT	Injury, poisoning and procedural complications	None	View
Wound dehiscence	SYSTEMATIC_ASSESSMENT	Injury, poisoning and procedural complications	None	View
Aphasia	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Cerebrovascular accident	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Dizziness	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Dysarthria	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Haemorrhage intracranial	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Hemiparesis	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Paraesthesia	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Seizure	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Confusional state	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Haemothorax	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Pleurisy	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Pulmonary embolism	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Rash maculo-papular	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Chest tube insertion	SYSTEMATIC_ASSESSMENT	Surgical and medical procedures	None	View
Craniotomy	SYSTEMATIC_ASSESSMENT	Surgical and medical procedures	None	View
Hip surgery	SYSTEMATIC_ASSESSMENT	Surgical and medical procedures	None	View
Thoracotomy	SYSTEMATIC_ASSESSMENT	Surgical and medical procedures	None	View
Deep vein thrombosis	SYSTEMATIC_ASSESSMENT	Vascular disorders	None	View
Enterovesical fistula	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Hip fracture	SYSTEMATIC_ASSESSMENT	Injury, poisoning and procedural complications	None	View
Haematoma	SYSTEMATIC_ASSESSMENT	Vascular disorders	None	View

Other Events(If Any):

Other Events

Term	Type	Organ System	Vocab	View

Eye pain	SYSTEMATIC_ASSESSMENT	Eye disorders	None	View
Visual impairment	SYSTEMATIC_ASSESSMENT	Eye disorders	None	View
Abdominal pain	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Constipation	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Diarrhoea	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Dry mouth	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Dysphagia	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Flatulence	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Gastritis	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Injection site pain	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site pruritus	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site rash	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site reaction	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site swelling	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Malaise	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Mucosal inflammation	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Non-cardiac chest pain	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Oedema peripheral	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Pain	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Peripheral swelling	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Pyrexia	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Hypersensitivity	SYSTEMATIC_ASSESSMENT	Immune system disorders	None	View
Bronchitis	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Influenza	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Haemoglobin urine present	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Lymphocyte count decreased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Neutrophil count decreased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Neutrophil count increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Platelet count decreased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Transaminases increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Urine ketone body present	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Weight decreased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Weight increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
White blood cell count decreased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
White blood cell count increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Paraesthesia	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Partial seizures	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Dysgeusia	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Headache	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Hemiparesis	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Memory impairment	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Mental impairment	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Neuralgia	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Hypothyroidism	SYSTEMATIC_ASSESSMENT	Endocrine disorders	None	View
Cataract	SYSTEMATIC_ASSESSMENT	Eye disorders	None	View
Gastrooesophageal reflux disease	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Nausea	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Oesophageal spasm	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Retching	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Vomiting	SYSTEMATIC_ASSESSMENT	Gastrointestinal disorders	None	View
Application site discolouration	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Asthenia	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Chills	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Cyst	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Face oedema	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Fatigue	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Gait disturbance	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Implant site oedema	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Influenza like illness	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site bruising	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site discharge	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site erythema	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site induration	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site inflammation	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site nodule	SYSTEMATIC_ASSESSMENT	General disorders	None	View
Injection site infection	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Lyme disease	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Respiratory tract infection	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Skin infection	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Tooth infection	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Upper respiratory tract infection	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Urinary tract infection	SYSTEMATIC_ASSESSMENT	Infections and infestations	None	View
Fall	SYSTEMATIC_ASSESSMENT	Injury, poisoning and procedural complications	None	View
Incision site complication	SYSTEMATIC_ASSESSMENT	Injury, poisoning and procedural complications	None	View
Spinal compression fracture	SYSTEMATIC_ASSESSMENT	Injury, poisoning and procedural complications	None	View
Wound complication	SYSTEMATIC_ASSESSMENT	Injury, poisoning and procedural complications	None	View
Alanine aminotransferase increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Aspartate aminotransferase increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Blood alkaline phosphatase increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Blood bilirubin increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Blood cholesterol increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Blood creatinine increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Blood glucose increased	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Blood ketone body	SYSTEMATIC_ASSESSMENT	Investigations	None	View
Decreased appetite	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Gout	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Hyperglycaemia	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Hyperkalaemia	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Hypernatraemia	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Hypoalbuminaemia	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Hypocalcaemia	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Hypoglycaemia	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Hypokalaemia	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Hyponatraemia	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Obesity	SYSTEMATIC_ASSESSMENT	Metabolism and nutrition disorders	None	View
Arthralgia	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Back pain	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Costochondritis	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Fasciitis	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Groin pain	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Limb discomfort	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Muscle discomfort	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Muscle spasms	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Muscular weakness	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Musculoskeletal discomfort	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Musculoskeletal pain	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Musculoskeletal stiffness	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Myalgia	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Neck pain	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Pain in extremity	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Pain in jaw	SYSTEMATIC_ASSESSMENT	Musculoskeletal and connective tissue disorders	None	View
Malignant melanoma in situ	SYSTEMATIC_ASSESSMENT	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	None	View
Amnesia	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Aphasia	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Ataxia	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Balance disorder	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Cerebrospinal fluid leakage	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Cerebrovascular accident	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Cognitive disorder	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Coordination abnormal	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Depressed level of consciousness	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Dizziness	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Presyncope	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Sciatica	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Seizure	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Seizure like phenomena	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Sinus headache	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Syncope	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Taste disorder	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Tremor	SYSTEMATIC_ASSESSMENT	Nervous system disorders	None	View
Affect lability	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Agitation	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Anxiety	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Confusional state	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Depression	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Dysphoria	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Hallucination	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Hallucination, visual	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Insomnia	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Libido decreased	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Mental disorder	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Sleep disorder	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Suicidal ideation	SYSTEMATIC_ASSESSMENT	Psychiatric disorders	None	View
Haematuria	SYSTEMATIC_ASSESSMENT	Renal and urinary disorders	None	View
Incontinence	SYSTEMATIC_ASSESSMENT	Renal and urinary disorders	None	View
Proteinuria	SYSTEMATIC_ASSESSMENT	Renal and urinary disorders	None	View
Cough	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Dyspnoea	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Dyspnoea exertional	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Nasal congestion	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Oropharyngeal pain	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Pulmonary embolism	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Sinus congestion	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Sinus pain	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Upper-airway cough syndrome	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Wheezing	SYSTEMATIC_ASSESSMENT	Respiratory, thoracic and mediastinal disorders	None	View
Alopecia	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Dermatitis acneiform	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Dry skin	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Erythema	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Hyperhidrosis	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Pain of skin	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Panniculitis	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Pruritus	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Rash	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Rash maculo-papular	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Skin disorder	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Skin hypertrophy	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Skin induration	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Skin lesion	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Skin mass	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Urticaria	SYSTEMATIC_ASSESSMENT	Skin and subcutaneous tissue disorders	None	View
Rotator cuff repair	SYSTEMATIC_ASSESSMENT	Surgical and medical procedures	None	View
Hypertension	SYSTEMATIC_ASSESSMENT	Vascular disorders	None	View
Hypotension	SYSTEMATIC_ASSESSMENT	Vascular disorders	None	View
Peripheral coldness	SYSTEMATIC_ASSESSMENT	Vascular disorders	None	View
Anaemia	SYSTEMATIC_ASSESSMENT	Blood and lymphatic system disorders	None	View
Thrombocytopenia	SYSTEMATIC_ASSESSMENT	Blood and lymphatic system disorders	None	View
Angina pectoris	SYSTEMATIC_ASSESSMENT	Cardiac disorders	None	View
Atrial fibrillation	SYSTEMATIC_ASSESSMENT	Cardiac disorders	None	View
Bradycardia	SYSTEMATIC_ASSESSMENT	Cardiac disorders	None	View
Tachycardia	SYSTEMATIC_ASSESSMENT	Cardiac disorders	None	View
Deafness	SYSTEMATIC_ASSESSMENT	Ear and labyrinth disorders	None	View
Excessive cerumen production	SYSTEMATIC_ASSESSMENT	Ear and labyrinth disorders	None	View
Hypoacusis	SYSTEMATIC_ASSESSMENT	Ear and labyrinth disorders	None	View
Tinnitus	SYSTEMATIC_ASSESSMENT	Ear and labyrinth disorders	None	View
Vertigo	SYSTEMATIC_ASSESSMENT	Ear and labyrinth disorders	None	View
Cushingoid	SYSTEMATIC_ASSESSMENT	Endocrine disorders	None	View